23rd June 2022 | Pharma Updates
Govt assist pharma MSMEs in meeting domestic and international regulatory norms
Under Pharmaceutical Technology Upgradation Assistance Scheme, the government would provide help to micro, small, and medium sized (MSMEs) companies in the pharma industry that have a track record of meeting national and international regulatory standards.
Public health & Indian pharma both in ruins as a result of Biocon bribery case
The 4% drop in Biocon’s stock price in early Wednesday trading is just the tip of the iceberg. India’s position as, in Prime Minister Narendra Modi’s words, “the pharmacy of the world” is at risk unless the problem is thoroughly investigated.
Pharma firms to be in Russia next month
The Trade Promotion Council of India (TPCI) has instructed the Indian Drugs Manufacturing Association (IDMA) to encourage companies to seize the opportunity and establish themselves as trustworthy partners in the Russian market.
AstraZeneca India expands cancer screening programme for women in Tamil Nadu
AstraZeneca India announced that it has expanded its Ganga Godavari Cancer Screening Programme to Tamil Nadu as part of its Corporate Social Responsibility efforts (CSR).
PGI doctors instructed not to meet with pharma reps before 1pm
“All department heads have been instructed not to entertain medical representatives or persons from private laboratories. Medical representatives may, however, meet with the doctors in their chambers after 1pm, ” stated the order from PGI director’s office.
Austrak looking at a unit in Pharma City
Hyderabad based pharma firm, Austrak Private Limited has expanded into the nephrology and urology sectors and is considering entering the critical care, gynaecology, and gastrointestinal formulations markets.
Galderma announced positive trial results for a skin drug
Galderma, owned by EQT, announced that its injectable drug nemolizumab helped patients with the rare skin disease prurigo nodularis in a trial, potentially supporting the owner’s plans to list the skincare company.
and then